AKT1 and cancer: Therefore, monitoring dynamic changes in LAMA3 expression could provide additional insight into PDAC progression and prognosis.In addition, previous reports have suggested that LAMA3 may interact with integrins to activate PI3K/AKT and MAPK signaling pathways, thereby promoting cancer cell survival, proliferation, and migration [29–31].